Histoplasmosis in the acquired immune deficiency syndrome.
This report describes the experience with disseminated histoplasmosis in seven of 15 patients with the acquired immune deficiency syndrome (AIDS) diagnosed in Indianapolis since 1981. Three were homosexual, two were intravenous drug addicts, one was the spouse of another patient with AIDS and disseminated histoplasmosis, and the seventh was a hemophiliac. Six had associated infections: candidiasis in three, Pneumocystis carinii pneumonia, recurrent mucocutaneous herpes simplex infection, and disseminated Mycobacterium avium infection in two each, and disseminated infection with an unidentified mycobacterium in one. Clinical diseases suggested sepsis in four. Histoplasma fungemia occurred in five, but the diagnosis was established first by visualization of organisms in blood or bone marrow in three. Results of Histoplasma serologic tests were positive in each. Three died before receiving 50 mg of amphotericin B, three had prompt improvement with amphotericin B, and one was treated with ketoconazole to prevent dissemination. However, two of the three patients treated with amphotericin B had relapses after a 35 mg/kg course, and the third died within a month following therapy. Disseminated histoplasmosis is a major opportunistic infection in patients with AIDS from endemic areas. AIDS should be strongly considered in otherwise healthy persons with disseminated histoplasmosis, especially if risk factors for AIDS are present. Amphotericin B is not curative in these patients.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D000328:Adult; D000666:Amphotericin B / Q000627:therapeutic use; D002177:Candidiasis / Q000188:drug therapy / Q000503:physiopathology; D005260:Female; D006561:Herpes Simplex / Q000503:physiopathology; D006660:Histoplasmosis / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D006716:Homosexuality; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D009164:Mycobacterium Infections / Q000503:physiopathology; D009162:Mycobacterium avium; D011020:Pneumonia, Pneumocystis / Q000503:physiopathology; D014376:Tuberculosis / Q000503:physiopathology
D000666:Amphotericin B; D007654:Ketoconazole